171 related articles for article (PubMed ID: 25586662)
1. Association of immunoexpression of the galectins-3 and -7 with histopathological and clinical parameters in oral squamous cell carcinoma in young patients.
Mesquita JA; Queiroz LM; Silveira ÉJ; Gordon-Nunez MA; Godoy GP; Nonaka CF; Alves PM
Eur Arch Otorhinolaryngol; 2016 Jan; 273(1):237-43. PubMed ID: 25586662
[TBL] [Abstract][Full Text] [Related]
2. Significance of galectins-1, -3, -4 and -7 in the progression of squamous cell carcinoma of the tongue.
Alves PM; Godoy GP; Gomes DQ; Medeiros AM; de Souza LB; da Silveira EJ; Vasconcelos MG; Queiroz LM
Pathol Res Pract; 2011 Apr; 207(4):236-40. PubMed ID: 21397408
[TBL] [Abstract][Full Text] [Related]
3. Galectin-9 as an important marker in the differential diagnosis between oral squamous cell carcinoma, oral leukoplakia and oral lichen planus.
Muniz JM; Bibiano Borges CR; Beghini M; de Araújo MS; Miranda Alves P; de Lima LM; Pereira SA; Nogueira RD; Napimoga MH; Rodrigues V; Rodrigues DB
Immunobiology; 2015 Aug; 220(8):1006-11. PubMed ID: 25956455
[TBL] [Abstract][Full Text] [Related]
4. A study on histological grading systems of oral squamous cell carcinoma and comparison of their efficacy in determining the nature (clinical and histopathological) and prognosis of oral squamous cell carcinoma.
Pandya JA; Natarajan S
J Cancer Res Ther; 2023 Apr; 19(Supplement):S198-S205. PubMed ID: 37147997
[TBL] [Abstract][Full Text] [Related]
5. Evaluation and Prognostic Significance of Galectin-3 Expression in Oral Squamous Cell Carcinoma.
Tokmak S; Arık D; Pınarbaşlı Ö; Gürbüz MK; Açıkalın MF
Ear Nose Throat J; 2021 Sep; 100(5_suppl):578S-583S. PubMed ID: 31838918
[TBL] [Abstract][Full Text] [Related]
6. Galectin 3 expression in primary oral squamous cell carcinomas.
Weber M; Büttner-Herold M; Distel L; Ries J; Moebius P; Preidl R; Geppert CI; Neukam FW; Wehrhan F
BMC Cancer; 2017 Dec; 17(1):906. PubMed ID: 29284429
[TBL] [Abstract][Full Text] [Related]
7. Galectins as modulators of tumor progression in head and neck squamous cell carcinomas.
Saussez S; Camby I; Toubeau G; Kiss R
Head Neck; 2007 Sep; 29(9):874-84. PubMed ID: 17315170
[TBL] [Abstract][Full Text] [Related]
8. Bryne's grading system predicts poor disease-specific survival of oral squamous cell carcinoma: a comparative study among different histologic grading systems.
Wagner VP; Webber LP; Curra M; Klein IP; Meurer L; Carrad VC; Martins MD
Oral Surg Oral Med Oral Pathol Oral Radiol; 2017 Jun; 123(6):688-696. PubMed ID: 28411003
[TBL] [Abstract][Full Text] [Related]
9. Changed expression of E-cadherin and galectin-9 in oral squamous cell carcinomas but lack of potential as prognostic markers.
Chan SW; Kallarakkal TG; Abraham MT
Asian Pac J Cancer Prev; 2014; 15(5):2145-52. PubMed ID: 24716948
[TBL] [Abstract][Full Text] [Related]
10. Key proteins of invadopodia are overexpressed in oral squamous cell carcinoma suggesting an important role of MT1-MMP in the tumoral progression.
Mitre GP; Balbinot KM; Ribeiro ALR; da Silva Kataoka MS; de Melo Alves Júnior S; de Jesus Viana Pinheiro J
Diagn Pathol; 2021 Apr; 16(1):33. PubMed ID: 33879222
[TBL] [Abstract][Full Text] [Related]
11. Effect of c-Met expression on survival in head and neck squamous cell carcinoma.
Lo Muzio L; Farina A; Rubini C; Coccia E; Capogreco M; Colella G; Leonardi R; Campisi G; Carinci F
Tumour Biol; 2006; 27(3):115-21. PubMed ID: 16612144
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical study of RhoC GTPase in oral squamous cell carcinoma.
Martins LH; Pinheiro NM; Spina AM; Micheletti AM; Carboni SS; Crema VO
Cell Mol Biol (Noisy-le-grand); 2015 Aug; 61(4):41-5. PubMed ID: 26278266
[TBL] [Abstract][Full Text] [Related]
13. Immunoexpression of hMSH2 and hMLH1 in oral squamous cell carcinoma and its relationship to histological grades of malignancy.
Fernandes AM; Ramos-Jorge ML; Cardoso SV; Loyola AM; Mesquita RA; Aguiar MC
J Oral Pathol Med; 2008 Oct; 37(9):543-8. PubMed ID: 18331286
[TBL] [Abstract][Full Text] [Related]
14. Galectin-1 and galectin-3: plausible tumour markers for oral squamous cell carcinoma and suitable targets for screening high-risk population.
Aggarwal S; Sharma SC; Das SN
Clin Chim Acta; 2015 Mar; 442():13-21. PubMed ID: 25578395
[TBL] [Abstract][Full Text] [Related]
15. Pattern of galectins expression in actinic cheilitis with different risks of malignant transformation.
Lopes ML; Nonaka CF; Queiroz LM; de Souza LB; Miguel MC; da Silveira ÉJ
J Oral Pathol Med; 2016 Sep; 45(8):621-6. PubMed ID: 26711374
[TBL] [Abstract][Full Text] [Related]
16. Immunoexpression of Epithelial Mesenchymal Transition Proteins E-Cadherin, β-Catenin, and N-Cadherin in Oral Squamous Cell Carcinoma.
Angadi PV; Patil PV; Angadi V; Mane D; Shekar S; Hallikerimath S; Kale AD; Kardesai SG
Int J Surg Pathol; 2016 Dec; 24(8):696-703. PubMed ID: 27312520
[TBL] [Abstract][Full Text] [Related]
17. Galectin 7 (p53-induced gene 1): a new prognostic predictor of recurrence and survival in stage IV hypopharyngeal cancer.
Saussez S; Cucu DR; Decaestecker C; Chevalier D; Kaltner H; André S; Wacreniez A; Toubeau G; Camby I; Gabius HJ; Kiss R
Ann Surg Oncol; 2006 Jul; 13(7):999-1009. PubMed ID: 16788763
[TBL] [Abstract][Full Text] [Related]
18. Alterations in the immunoexpression of galectins-1, -3 and -7 between different grades of oral epithelial dysplasia.
de Vasconcelos Carvalho M; Pereira Jdos S; Alves PM; Silveira EJ; de Souza LB; Queiroz LM
J Oral Pathol Med; 2013 Feb; 42(2):174-9. PubMed ID: 22845866
[TBL] [Abstract][Full Text] [Related]
19. Galectins-1, -3, and -7 Are Prognostic Markers for Survival of Ovarian Cancer Patients.
Schulz H; Schmoeckel E; Kuhn C; Hofmann S; Mayr D; Mahner S; Jeschke U
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28594391
[TBL] [Abstract][Full Text] [Related]
20. Serum big endothelin-1 as a biomarker in oral squamous cell carcinoma patients: an analytical study.
Mankapure PK; Barpande SR; Bhavthankar JD; Mandale M
J Appl Oral Sci; 2015 Oct; 23(5):491-6. PubMed ID: 26537720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
